IGFBP5 and central nervous system cancer: Our results indicated that higher expression of IGFBP5 was associated with a reduction of B and NK cells in glioma, and that less either B or NK cells could activate antitumor immune response and induce immune escape, which in turn, contributed to poor prognosis.